Official recall notice

FDA DrugClass IINotable

Diovan Recall (Aug 2026) – Novartis Pharmaceuticals

Product: Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutical Corp, East Hanover, NJ 07936, NDC 0078-0359-34

Recall date
2026-08-19
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

Failed Dissolution Specifications

One email a week when there are new recalls. Confirm by email; unsubscribe anytime.

Product description

Failed Dissolution Specifications

Affected products

Lot AV5913C, Expiry: 6/2027

Verify with the official notice →
Share:

Related Recalls

2026-10-09 · FDA_DRUG
FDA Recall: Par Pharmaceutical: Brevital Sodium 500 mg/vial for Injection
Par Pharmaceutical
2026-10-01 · FDA_DRUG
FDA Recall: Greenwich: Glutathione Injection
Greenwich
2026-10-01 · FDA_DRUG
FDA Recall: Greenwich: Glutathione Injection
Greenwich
2026-09-30 · FDA_DRUG
FDA Recall: Reliable -1 Laboratories, Sodium Chloride Hypertonicity Ophthalmic Solution, 5%, Sterile, 0.5 FL OZ
Sterling Pharmaceutical Services LLC